Skip to content

For Patients

Get the answers you need with our exhaustive genetic testing.

Get Started

It can be frustrating to explore uncertainties on your own.

When it comes to your health or that of your loved ones, you may want to make sure you explore all possible options. Our whole genome diagnostic testing is designed to help uncover critical information other tests could have missed.

Whole Genome Coverage

Standard panel testing looks at less than 0.1% of your genome1, leaving lots of room for unanswered questions. Our whole genome sequencing platforms provide an extensive analysis of your genomic makeup, including complex mutations (structural variants, copy number variants, variants in non-coding areas) that are not covered by other panel and exome sequencing tests.

Targeted Panel Sequencing

< 0.1 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations

Whole Exome Sequencing

1 – 2 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations
  • Non-coding areas not covered

Whole Genome Sequencing

> 99 %

Genome-wide coverage

  • More point mutations identified
  • More accurate, genome-wide copy number variations
  • Genome-wide coverage of structural variations
  • Non-coding areas also covered

Personalized Reports

Our test report is comprehensive and easy to understand. It will provide insights to help you and your healthcare provider make informed decisions tailored to your unique body, empowering you on your healthcare journey.

Genetic Counseling Support

We don’t just send you a report and leave it to you to interpret it; we facilitate access to genetic counseling to guide you through your results line-by-line to make sure you understand the findings and your options.

Clinical Trial Matching Support

Only 8% of eligible cancer patients2 are enrolled in clinical trials in the US, which presents challenges to find and enroll in matched clinical trials. We identify clinical trial matches based on your biomarkers, along with additional criteria, and connect you with enrollment support services up on your request.

* Note – Clinical trial matching support is currently available only for cancer patients. We are working to expand it to other disease areas.

Available Tests

Whether you’re looking for more treatment options or a diagnosis, our tests can provide the supporting data you need.

Cancer

See your cancer from new angles. Did you know more than 25% of cancer patients3 have complicated mutations that are often missed in standard panel sequencing (e.g., Next Generation Sequencing panel for 300-500 genes) and Whole Exome Sequencing? Our whole genome test unveils a comprehensive picture of your genome including complicated mutations and helps you explore answers you need.

CancerVision

This test is for cancer patients who are diagnosed with a solid tumor that was recently diagnosed, is recurring, or that has not responded to treatments. You will get:

  • Whole genome sequencing that covers not only point mutations but also complicated mutations*
  • Genetic mutation-linked treatment options
  • Additional biomarkers associated with personalized therapy selection
  • Clinical trials matched with your biomarkers and mutations
  • Access to genetic counseling to help you understand the findings
  • 2-week turnaround time**

Price: $4,000***

* Includes copy number variants, structural variants, and variants in non-coding areas (introns).
** 2 weeks from receipt of your tissue and blood samples at our lab.
***The listed price is a general estimate. The price may vary depending on your country and the specific scope of services we provide tailored to your needs.

Rare Disease

Shorten the time to get the right diagnosis. It can take an average of 4-5 years4 to get a diagnosis of a rare disease, and almost 40% of rare disease patients5 received a misdiagnosis in their journey. Our whole genome test enhances variant detection sensitivity, allowing for a more sophisticated understanding of rare diseases.

RareVision

This test is for patients or family members who are looking for a confirmative diagnosis of a rare disease and/or an answer behind several rare disease symptoms. You will get:

  • Whole genome sequencing that covers not only point mutations but also complicated mutations* 
  • Genes associated with rare diseases from one of the most up-to-date databases6 
  • Secondary findings with clinical intervention suggestions
  • Access to genetic counseling to help you understand the findings
  • 2-week turnaround time** 

Price: $2,400***

* Covers copy number variants, structural variants and transposable elements including variants in non-coding regions.
** 2 weeks from receipt of your tissue and blood samples at our lab.
*** The listed price is a general estimate. The price may vary depending on your country and the specific scope of services we provide tailored to your needs.

How to Order a Test

Ordering a whole genome sequencing test from Inocras is easy and simply requires a discussion with your doctor.

01.

Talk with your doctor about testing options.

02.

Your doctor orders the test.

03.

Your doctor collects samples to be tested.

04.

Inocras sends a report to your doctor.

05.

Discuss results and treatment plans.

Email us at inquiry@inocras.com if you need support. We can help facilitate the process by working with your doctor. 

Case Studies

Breast Cancer Patient Finds Hope in New Treatment Options

Sarah, 40 years old, was previously treated for breast cancer at 20 and was diagnosed with pancreatic cancer. She had several genetic tests such as a tissue panel test and hereditary cancer panel test, but they failed to reveal the cause of her disease. The CancerVision test provided potential. It uncovered a complex structural variant (Large Deletion with Inversion, LDI) in her germline BRCA1 gene. Additionally, it detected the characteristic Homologous Recombination Deficiency (HRD) pattern associated with BRCA1. This finding opened up a range of treatment options specifically designed for patients with BRCA1-related breast cancer.

Case Studies

Teen Receives Definitive Diagnosis & Possible Cure

Chloe, 17, had severe symptoms that affected her intestines. Doctors suspected inflammatory bowel disease (IBD), but finding the exact cause remained a challenge. The results from our whole genome sequencing test revealed two pathogenic variants that confirmed her diagnosis of early-onset IBD. She learned that IBD caused by her mutations can be treated, and even cured, through hematopoietic stem cell transplantation. She is now actively preparing for transplantation, a potential solution for her condition.

Case Studies

Lung Cancer Patient Sees Improved Prognosis With Targeted Treatment

John, 40, diagnosed with lung cancer, experienced a frustrating setback when the drug prescribed for his EGFR mutation failed to slow down the cancer’s progression. Feeling hopeless, he turned to the CancerVision test for a potential breakthrough. The test revealed a genetic alteration in a non-coding area (NTRK3::EML4 Fusion) that would have been difficult to detect through a standard panel test or exome test. Fortunately, there was a targeted drug available for this specific gene. John transitioned to this treatment, which led to positive changes in his prognosis.

Case Studies

Family Finds Answers for Perplexing Symptoms

Andrew, a 1-year-old boy, was experiencing a myriad of perplexing symptoms, including decreased muscle tone, dysmorphism, and a failure to thrive. With the hope of finding answers, Andrew’s provider ordered the RareVision test. The results revealed a pathogenic variant that led to a definitive diagnosis of a rare genetic disorder called Noonan syndrome. This finding provided a roadmap for his future care that allowed his family to take proactive steps in managing his health.

*While all patient names provided are fictionalized to ensure privacy and confidentiality, the age, disease information, and diagnostic process in the testimonials are based on real cases. Please note that clinical outcomes may vary for each individual.

Frequently Asked Questions

If you don’t see your question answered here, please contact us.

How do I order a test?

To order the test, you’ll need to have a conversation with your doctor who can then order the test for you. These tests are currently not available for ordering without the guidance of a licensed healthcare provider. Email us at inquiry@inocras.com if you need support. We can help facilitate the process by working with your doctor.

Would my insurance cover Inocras’s whole genome sequencing tests?

Currently, our whole genome sequencing tests are not yet covered by insurance in the US. We are working on insurance coverage to provide easy access to all patients. Outside of the US, our products may be covered by insurance, but it significantly varies by the country and types of insurance. We suggest reaching out to your insurer to confirm. If you need any support exploring it, please contact us at inquiry@inocras.com.

How are my samples sent to Inocras?

As a patient, all you have to do is talk with your doctor about the test. Your doctor will then order the test, collect the sample, and send it directly to us. The rest of the process is handled by our team.

What kind of samples are collected?

The type of sample(s) collected depends on which test you are ordering. Here are the sample types by test:

  • CancerVision: Blood and tissue samples
  • RareVision: Blood sample
How will my results be shared with me?

Your test results will be sent back to the doctor who ordered your test, who will discuss the results with you.

How long does it take?

We prioritize delivering results promptly and aim for efficiency in our processes. Our current turnaround time is 14 days from receipt of samples on average, aligning with the industry’s best-in-class testing standards.

This ensures patients receive their results in a timely manner, enabling healthcare providers to make informed decisions about their care. However, please note that the time from ordering the test to receiving results may vary depending on how long it takes for samples to reach our laboratory.

Would my genetic data be safe?

At Inocras, your privacy matters. We take the protection of your genetic data seriously. Here’s how we keep your information safe:

  • Top-Notch Security: We implement robust encryption for sensitive portions of your data within our database to protect you.
  • Limited Information: We only store essential data to minimize your data footprint.
  • Controlled Access: Access to your data is strictly limited to key personnel to protect your privacy.
  • Legal Compliance: We follow HIPAA regulations in the US. Keeping your data safe is not just our policy; it’s our legal obligation.
  • Your Consent Matters: We don’t share your data with anyone else without getting your consent first.
  • Open Policies: Our privacy policy is there for you to see on our website. It explains how we use and protect your data.
  • Always Up to Date: We constantly review and improve our security measures to combat new threats and embrace new safety technologies.

We’re committed to earning your trust by handling your genetic information with the utmost care and respect. If you have questions or need more information about how we protect your data, send us an email at inquiry@inocras.com.